Last Updated
Overview
VOINOSIS analyzes voice and eye signals to support early cognitive decline and hearing loss screening, aiding faster clinical assessment. Though its integration options currently center on EMR systems, its proprietary acoustic biomarkers and award-winning accuracy make VOINOSIS a compelling choice for brain health screening.
Be the first one to leave a review!
No review found
Starting Price
Custom
VOINOSIS Specifications
- Telemedicine
- Appointment Management/Scheduling
- e-Prescriptions
- Lab Integration
What Is VOINOSIS?
VOINOSIS is a voice AI platform designed to detect early signals of cognitive and mental health changes through voice analysis. It offers BrainGuard Doctor, a clinical screening solution that analyzes cognitive and behavioral responses in under a minute for hospitals and medical institutions.
The software also offers HAHA CARE, a hearing and cognitive wellness solution that helps seniors check their hearing and cognitive status through personalized training programs. Together, these solutions connect clinical screening with everyday brain health management.
What Is VOINOSIS Best For?
The platform is well known for its 'AI-Powered Cognitive Screening', which combines voice and eye-tracking analysis to quantify cognitive and behavioral responses in under a minute, giving clinicians fast, objective screening results without relying on manual evaluation alone.
How Much Does VOINOSIS Cost?
VOINOSIS pricing typically falls between $350 and $1,000/month, based on industry benchmarks for AI-powered EMR and voice-based clinical assessment platforms.
Following are the additional estimated cost you need to consider before planning:
- Clinical AI And Voice Analysis: $100–$500/month – For advanced speech analysis, cognitive screening, voice biomarkers, and longitudinal patient insights
- EMR And Healthcare Integrations: $500–$3,000 one-time – For connecting VOINOSIS with existing EMR systems, patient records, or clinical workflows
- Data Security And Compliance: $200–$1,000/month – For enhanced healthcare data protection, audit controls, access management, and compliance requirements
- Implementation And Clinical Onboarding: $1,000–$5,000 one-time – For configuring clinical workflows, training staff, and deploying the platform across a practice or healthcare organization
Disclaimer: Pricing references are based on publicly available third-party information and industry benchmarks. Actual costs may vary.
VOINOSIS Integrations
The vendor has not listed any available third-party integrations for this software.
How Does VOINOSIS Work?
Here is how you can get started with VOINOSIS once onboarding is complete:
- Access the dashboard to view screening results and patient assessment summaries
- Launch a BrainGuard Doctor session to begin a new cognitive screening
- Guide the patient through picture description, counting backward, and eye tracking tasks
- Review quantified cognitive and behavioral scores generated after each session
- Compare current results against previous screenings to track changes over time
- Enroll patients in HAHA Care for ongoing hearing and cognitive monitoring at home
- Assign personalized auditory-cognitive training content based on each patient's profile
- Share screening outputs with the care team to support treatment decisions
Who Is VOINOSIS For?
VOINOSIS software is suitable for a wide range of industries, clinics, and research institutions, including:
- Hospitals
- Medical institutions
- Memory clinics
- Senior care providers
- Healthcare researchers
- Digital health partners
VOINOSIS Use Cases
Based on our analysis of VOINOSIS's current capabilities and typical clinical applications, we have identified key scenarios where this software is a strong fit for hospitals, senior care providers, and digital health teams:
Hospitals Screening For Early Dementia Risk
Clinical teams can use BrainGuard Doctor to complete a multi-task cognitive assessment in under a minute during a standard visit. This gives physicians an objective, quantified score instead of relying solely on subjective judgment. The format is designed to slot into existing clinical workflows without extending appointment times. Hospitals running high patient volumes can use this to flag at-risk individuals earlier and route them to further evaluation.
Clinics Serving Patients With Language Or Literacy Barriers
Combining voice with eye-tracking gives care teams a screening path for patients who struggle with verbal tasks or written instructions. The multimodal approach cross-checks results across two signal types rather than depending on speech alone. This is useful for clinics serving diverse or non-native-speaking populations where standard verbal tests may under-detect early decline. It gives clinicians a more dependable read in cases where language would otherwise limit accuracy.
Senior Care Providers Managing At-Home Monitoring
Providers supporting aging populations can use HAHA Care to let seniors check hearing and cognitive status through short voice-based tasks at home. Personalized auditory-cognitive training then adjusts to each person's specific acoustic profile. This suits senior living communities or home-care programs looking to keep tabs on residents between formal clinical visits. It shifts monitoring from a once-a-year checkup to an ongoing, low-effort routine.
Health Systems Connecting Screening To Long-Term Follow-Up
Care teams can route a patient from a hospital-based BrainGuard Doctor screening directly into HAHA Care once they return home. This closes the gap between a single clinical assessment and continuous management rather than treating screening as a one-time event. Health systems building integrated dementia-care pathways can use this connection to keep a consistent record of a patient's cognitive trajectory. It also gives care coordinators a trigger point for re-screening if decline is suspected later.
Is VOINOSIS Right For You?
Looking for a way to identify early cognitive changes and support ongoing brain health? VOINOSIS combines clinical cognitive screening with hearing and cognitive wellness tools, connecting clinical assessment with everyday care.
VOINOSIS collaborates with healthcare and research institutions, including Mount Sinai Hospital and Samsung Medical Center, to validate its clinical AI technology. Its voice AI technology has also gained international recognition through the ICASSP 2023 Multilingual Alzheimer’s Detection challenge and Global Startup World Cup.
Still not sure if the software is right for you? Contact us at (661) 384-7070, and we will help you make the best decision regarding VOINOSIS features and more.
VOINOSIS Features
Voice-Based Health Analysis
Rather than transcribing speech to text, this capability captures raw vocal signals such as speech rate, intensity, and micro-tremors. These physical traits act as direct indicators of underlying health changes that exist beneath conscious control. Clinicians can gain a screening signal that supports confident decision-making during patient evaluations.
Multimodal Cognitive Screening
Fusing speech data with eye-tracking signals gives this capability a second, independent data stream to check results against. Patients with limited language ability or literacy can still be screened accurately under this approach. Care teams gain cross-verified outputs instead of depending on a single modality, strengthening confidence in each assessment.
Proprietary Acoustic Biomarkers
This capability quantifies subtle vocal characteristics, including pitch variation, speech rate, and micro-tremors, that conventional speech recognition tools typically overlook. Because these biomarkers exist beneath conscious control, they offer a physical signal that self-reported symptoms cannot fully capture. Care teams use this output to support more objective, data-backed screening conversations.
Multilayer Signal Decoding
Speech is processed in layers under this capability, moving from individual phonemes up through phrases to full utterances rather than treating voice as one flat signal. Each clinical task draws on the extraction layer best suited to it, keeping the analysis matched to what is being measured. This layered approach helps care teams trust the precision behind each result.
Cognitive Health Monitoring
Once an initial screening is complete, this capability extends tracking into everyday settings through repeated, low-effort check-ins rather than a single clinical snapshot. Personalized training content adjusts to each person's specific acoustic and cognitive profile over time. This ongoing view gives care teams a clearer basis for deciding when a patient may need further follow-up.
Pros And Cons of VOINOSIS
Pros
Combines voice and eye-tracking to improve screening accuracy
Completes cognitive screening within a minute for faster assessments
Uses acoustic biomarkers to identify subtle cognitive changes
Cons
AI results may need validation by healthcare professionals
Voice-based analysis may not capture every cognitive factor
VOINOSIS Reviews
No reviews yet!
Be the first to review this product
Frequently Asked Questions
Does VOINOSIS have a mobile app?
No, VOINOSIS does not have a dedicated mobile app.
Does VOINOSIS offer an API?
The vendor has not shared information about its API.
What languages does VOINOSIS support?
VOINOSIS primarily supports English, Korean, and Japanese languages.
What types of pricing plans does VOINOSIS offer?
VOINOSIS pricing typically ranges between $350 and $1,000/month. Request a custom VOINOSIS price quotation.
Who are the typical users of VOINOSIS?
VOINOSIS serves hospitals, medical institutions, memory clinics, and senior care providers, along with individual seniors managing hearing and cognitive health at home.
What level of support does VOINOSIS offer?
VOINOSIS offers support through phone, email, and contact form.
What other apps does VOINOSIS integrate with?
The vendor has not shared information about its third-party integration.